Table 1 Demographic and clinical characteristics of CAD-, CAD+
From: A-kinase anchoring protein 1: an independent predictor of coronary artery disease
Variable | CAD- | CAD+ | P value |
|---|---|---|---|
Male | 46 (68.7%) | 139 (73.9%) | 0.4061 |
Age, yrs | 63 (55, 69) | 65 (56, 71) | 0.5392 |
Smoking | 13 (19.4%) | 56 (29.8%) | 0.1001 |
Hypertension | 55 (82.1%) | 148 (78.7%) | 0.5571 |
Diabetes mellitus | 13 (20.1%) | 79 (42.0%) | < 0.011 |
Hyperlipidemia | 25 (37.3%) | 86 (45.7%) | 0.2321 |
Body mass index, kg/m2 | 24.82 ± 3.61 | 25.03 ± 2.63 | 0.6623 |
Systolic blood pressure, mmHg | 130 (121, 142) | 133 (120, 145.5) | 0.9072 |
Diastolic blood pressure, mmHg | 80 (74, 90) | 80 (72, 88) | 0.3502 |
Alanine transaminase, U/L | 19.00 (15.00, 31.00) | 20.40 (14.00, 29.95) | 0.9432 |
Creatinine, mg/dL | 69.00 (57.00, 78.40) | 69.40 (61.35, 79.85) | 0.1982 |
Fasting blood-glucose, mmol/L | 5.22 (4.75, 5.79) | 5.19 (4.51, 6.57) | 0.9182 |
Glycosylated hemoglobin, % | 6.0 (5.7, 6.3) | 6.3 (5.8, 7.3) | 0.0042 |
Total cholesterol, mmol/L | 4.20 (3.27, 4.96) | 4.31 (3.64, 5.00) | 0.1792 |
Triglyceride, mmol/L | 1.46 (0.93, 1.81) | 1.49 (1.07, 2.06) | 0.4242 |
High-density lipoprotein, mmol/L | 1.07 (0.96, 1.20) | 0.95 (0.82, 1.17) | 0.0022 |
Low-density lipoprotein, mmol/L | 2.65 (2.03, 3.15) | 2.50 (1.96, 3.28) | 0.7552 |
C-reactive protein, mg/L | 0.33 (0.21, 1.34) | 1.43 (0.42, 5.17) | < 0.012 |
LVEF, % | 68.00 (62.75,73.00) | 62.00 (56.00,68.00) | < 0.012 |
AKAP1, ng/mL | 0.62 (0.44,0.88) | 0.42 (0.29,0.73) | < 0.012 |
Aspirin | 18 (26.9%) | 65 (34.6%) | 0.2481 |
Statins | 14 (20.9%) | 61 (32.4%) | 0.0751 |
Antihypertensive medication | 43 (64.2%) | 123 (65.4%) | 0.8541 |
Antidiabetic therapy | 6 (9.0%) | 62 (33.0%) | < 0.011 |